Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FPNSF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,568
Award facts
- Contract value 100% obligated
- $31,568.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,568.38 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on September 11, 2025, with completion targeted for September 12, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
This procurement supports the Defense Health Agency and military healthcare systems' pharmaceutical supply chain requirements. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis—products essential to military medical readiness. The award reflects AmerisourceBergen's proven capability to meet federal procurement standards through open competition and its significant role in supporting the Defense Logistics Agency's pharmaceutical prime vendor program serving military and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2DB25FPNSF?
SPE2DB25FPNSF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FPNSF worth?
The government has obligated $31,568 on SPE2DB25FPNSF.
Is contract SPE2DB25FPNSF an order under another contract?
Yes. SPE2DB25FPNSF is a delivery order under SPE2DB20D2001, an indefinite delivery contract.
Was contract SPE2DB25FPNSF competed?
The extent of competition for SPE2DB25FPNSF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award